PillFosfomycin Tromethamine
Fosfomycin Tromethamine
7 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it7 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Aucta Pharmaceuticals, Inc. | unknown | 2 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 1 | SUPPLYING |
| A-S Medication Solutions | unknown | 1 | SUPPLYING |
| Kesin Pharma Corporation | unknown | 1 | SUPPLYING |
| Ascend Laboratories, LLC | unknown | 1 | SUPPLYING |
| Cipla USA Inc. | unknown | 1 | SUPPLYING |
| Amneal Pharmaceuticals LLC | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jan 16, 2024RECALLRecall (Class II): Fosfomycin Tromethamine Granules for Oral Solution, (equivalent to 3 grams of fosfomycin), single-dose sachet, Rx Only,…
Failed Impurities/Degradation Specification: Out of specification for organic impurities — Recalling firm: Ascend Laboratories, LLC — Nationwide in the USA
- Jul 18, 2023RECALLRecall (Class III): Fosfomycin Tromethamine Granules for Oral Solution, 3 g single- dose sachet, Rx only, Manufactured by: Alkem Laboratori…
Failed Impurities/Degradation Specifications: Out-of-specification results observed for the organic impurities test at 6 months, RT Stability. — Recalling firm: Ascend Laboratories, LLC — The recall product was distributed nationwide.